Study highlights lack of clinical research to address sight loss in working-age people

A new study has highlighted a lack of clinical research to address the leading causes of severe sight impairment (SSI) among the working-age UK population, which costs the UK economy an estimated £7.4bn annually.

Formycon AG increases its outlook for the 2024 fiscal year – Biotech Investments

Formycon AG / Key word(s): Preliminary Results/Forecast Formycon AG increases its outlook for the 2024 fiscal year 06-Aug-2024 / 12:40 CET/CEST Disclosure of an inside

August 7, 2024

Amgen nabs new Blincyto approval for certain type of leukemia

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 18, 2024

Steroid Tapering Called Safe in Older RA Patients

Most rheumatoid arthritis (RA) patients 65 and older who had 5 mg/day of prednisolone added to standard care were successfully weaned from the steroid without

August 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.